Cytokines and cytokine receptors as targets of immune-mediated inflammatory diseases—RA as a role model

Inflammation and Regeneration

Review

Tsutomu Takeuchi¹ 

[1] Saitama Medical University, 38 Morohongo, Moroyama, Iruma, 350-0495, Saitama, Japan;Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Keio University, 35 Shinanomachi, Shinjuku, 160-8582, Tokyo, Japan;

关键词: Immune-mediated inflammatory diseases;    Biological agents;    JAK inhibitors;    Cytokine;    Cytokine receptor;   

DOI  :  10.1186/s41232-022-00221-x

 received in 2022-06-21, accepted in 2022-07-15,  发布年份 2022

来源: Springer

【 摘 要 】

Recent advances in our understanding in the immune-mediated inflammatory diseases (IMID) are explored and promoted by the targeted treatment. Among these targets, cytokines and cytokine receptors have become the good candidates for the drug development. In this review, the cytokine and cytokine receptors, which are approved in IMID, are overviewed, and modalities of the treatment, the role of cytokines and cytokine receptors in each disease, and the updated molecular information by modern technologies in rheumatoid arthritis as a role model are shown and discussed for the future perspectives.

【 授权许可】

CC BY   
© The Author(s) 2022. corrected publication 2022

【 图 表 】

Fig. 1

Fig. 1

Fig. 1

Fig. 3

12936_2022_4386_Article_IEq142.gif